Table 1.

Summary of Patient Characteristics and Outcome

No	age at AuSCT	gender	diagnosis	surgery pre AuSCT	disease site at HDT	status at AuSCT	time between diagnosis and AuSCT (months)	Regimen*	status post AuSCT	surgery post AuSCT	TTP (months)	status	time to last follow up/death (months)
1	39	M	ES	Y	Rib	CR1	11	e	CR1	N	NA	A	57
2	20	F	ES	Y	Lung	CR2	38	c	CR2	N	9	D	13
3	24	F	ES	Y	Brain	CR2	37	f	CR2	N	NA	A	3
4	32	M	ES	N	Pelvis	PR1	4	g, b	PR1	N	32	D	64
5	20	M	ES	N	Scapula Clavicle	PR1	6	g, b	PR1	N	4	D	5
6	24	M	PNET	Y	Brain	PR2	52	f, b	SD2	N	NA	A	4
7	41	M	ES	Y	Tibia	PR1	8	a, a	PROG1	N	3	D	4
8	24	M	ES	N	Lung Bones	ProD2	40	c	PR2	Y	5**	D	5
9	27	M	ES	N	Spine	ProD1	7	d	PROG1	N	5	D	2
10	26	M	ES	Y	Spine	SD1	23	g, b	SD1	N	5	D	6
11	25	M	OS	Y	Lung	CR2	17	a, a	CR2	N	7	D	15
12	21	M	OS	Y	Lung	CR4	84	a, b	CR4	N	NA	A	12
13	24	M	OS	Y	Node, Rib, Scapula	CR2	24	a, a	CR2	N	6	D	25
14	22	M	OS	Y	Lung	ProD2	34	a	PR2	N	3	D	5
15	28	M	OS	Y	Lung	ProD3	32	a, b	PR3	N	10	D	13
16	21	M	RMS	Y	bladder	PR1	13	g, h	CR1	N	NA	A	92
17	34	F	RMS	Y	face	PR1	5	g, i	CR1	N	NA	D	7

AuSCT = autologous stem cells transplant, TTP = time to progression,*See text for details of conditioning regimen, ES = Ewing's Sarcoma, PNET = Peripheral Neuroectodermal Tumor, OS = osteosarcoma, RMS = rhabdomyosarcoma, CR = Complete Remission, PR = Partial Remission, ProD = Progressive disease, SD = stable disease, NA = Not Applicable, A = alive, D = dead, **Travelled back to his native country and died (cause unknown but assumed to be disease-related).